[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.94.5. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 1,268
Citations 0
Correction
June 14, 2016

Incorrect Reference Citations and Figure Labeling

JAMA. 2016;315(22):2472. doi:10.1001/jama.2016.6779

In the Original Investigation entitled “Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma,” published in the April 19, 2016, issue of JAMA,1 article text was attributed to incorrect reference citations and 2 Figures were incorrectly labeled. In the Study Design and Conduct section, a phrase that reads “and a cohort that included both ipilimumab-naive10-13” should be attributed to references 10 and 11. In Figure 3 and Figure 5, the black line within the key should be labeled as “Total” and the blue line should be labeled as “Treatment naive.” This article was corrected online.

References
1.
Ribas  A, Hamid  O, Daud  A,  et al.  Association of pembrolizumab with tumor response and survival among patients with advanced melanoma. JAMA. 2016;315(15):1600-1609.
PubMedArticle
×